Seeking Alpha Portfolio App for iPad
Dividends & Income
This user currently has no profile.
Biophile is an award winning small business person, and trained biochemist (Emory - Ph.D.; Harvard Med School - Post Doc) with professional interest in clinical informatics, small business management and valuation, and drug development. A former prep school chemistry instructor and cross country runner/skier, his professional goal is to organize the complex disciplines of drug compound identification, validation, and target management, especially as they act against bacterial and viral pathogens, for the purposes of clinical infection control, and microbial pathogen surveillance, vaccine development. Side interests include biofuels and intermediary metabolic pathway design. He designs protein sequence analysis and other
novel life science informatics algorithms, in order to devise new principles on which to order research information meaningfully.
These same principles can drive the evolution of companies.
Energy stocks, Options, REITs, Stocks - long, Tech stocks
Currently, there is no company profile for Biophile6.
Currently, there are no blog details for Biophile6.
Currently, there are no book details for Biophile6.
$IGXT: With three NDAs, will Intelgenx make the leap from OTC:QX to Nasdaq in 2013?
Dec 2, 2012
Outstanding depth and finan...
American Capital Agency Corp.'s Upcoming Q2 201...
Nice discussion. To add, al...
Canadian Biotech Isn't Dead; Following The Mone...
Hi frog. Suprised you did n...
Small Market Cap Pharmaceuticals With Large Cat...
Only some the above informa...
Recent Performance Review Of 5 Uranium Producer...
Not to be too nationalistic...
Why Large Miners Are Looking Into Small Uranium...
The Opinion Leaders
Xignite quote data
© 2013 Seeking Alpha